论文信息 - 1α‐HYDROXYVITAMIN D3 IN PRIMARY HYPERPARATHYROIDISM

1α‐HYDROXYVITAMIN D3 IN PRIMARY HYPERPARATHYROIDISM

The surgcal management of primary hyperparathyroidism with severe bone disease (and tertiary hyperparathyroidism) has frequently been complicated by severe and prolonged post‐operative hypocalcaemia. In seven such cases a short pre‐operative course of l α‐hydroxy vitamin D3 has been found to abolish these adverse features virtually completely and even to diminish pre‐operative symptoms where present. Exacerbation of hypercalcaemia has not occurred and this regimen is thus recommended as a routine measure.

[1] M. Christensen,et al. CONTROLLED TRIAL OF 1α-HYDROXYCHOLECALCIFEROL IN CHRONIC RENAL FAILURE , 1976, The Lancet.

[2] M. Haussler,et al. THE ASSAY OF 1α, 25‐DIHYDROXYVITAMIN D3: PHYSIOLOGIC AND PATHOLOGIC MODULATION OF CIRCULATING HORMONE LEVELS , 1976, Clinical endocrinology.

[3] C. Dent,et al. MASKED PRIMARY (OR TERTIARY) HYPERPARATHYROIDISM , 1975, The Lancet.

[4] S. Massry,et al. 1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy. , 1974, Archives of internal medicine.

[5] S. Stanbury,et al. Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism. , 1974, The American journal of medicine.

[6] H. DeLuca,et al. A rapid assay for 25-OH-vitamin D3 without preparative chromatography. , 1974, The Journal of clinical endocrinology and metabolism.

[7] J. Bilezikian,et al. Primary hyperparathyroidism: clinical and biochemical features. , 1974, Medicine.

[8] P. Bordier,et al. Vitamin D administration in primary hyperparathyroidism. , 1973, Clinical science.

[9] P. Bordier,et al. Quantitative histology of metabolic bone disease , 1972 .

[10] F. Doyle,et al. Vitamin-D deficiency and primary hyperparathyroidism. , 1971, Lancet.

[11] C. Anast,et al. Double-antibody radioimmunoassay for parathyroid hormone. , 1974, The Journal of laboratory and clinical medicine.